Laura Murray-Nerger, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Virus Latency | 2 | 2024 | 354 | 1.510 |
Why?
|
| Herpesvirus 4, Human | 3 | 2024 | 1076 | 1.390 |
Why?
|
| Viral Matrix Proteins | 2 | 2024 | 193 | 1.060 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2024 | 433 | 1.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 420 | 0.850 |
Why?
|
| Virus Activation | 1 | 2024 | 319 | 0.800 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2024 | 614 | 0.780 |
Why?
|
| Lamins | 1 | 2021 | 37 | 0.770 |
Why?
|
| Lamin Type B | 1 | 2021 | 26 | 0.750 |
Why?
|
| Lymphoma, B-Cell | 1 | 2024 | 938 | 0.590 |
Why?
|
| Histones | 1 | 2024 | 2570 | 0.440 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2021 | 1967 | 0.430 |
Why?
|
| DNA Repair | 1 | 2021 | 2041 | 0.380 |
Why?
|
| B-Lymphocytes | 4 | 2024 | 4744 | 0.360 |
Why?
|
| Cell Nucleus | 2 | 2021 | 2881 | 0.200 |
Why?
|
| Burkitt Lymphoma | 1 | 2024 | 335 | 0.200 |
Why?
|
| Herpesvirus 8, Human | 1 | 2023 | 255 | 0.190 |
Why?
|
| Nuclear Lamina | 1 | 2021 | 46 | 0.180 |
Why?
|
| Genome, Viral | 1 | 2024 | 665 | 0.170 |
Why?
|
| Bacillus | 1 | 2020 | 77 | 0.170 |
Why?
|
| Chromatin | 2 | 2021 | 2946 | 0.160 |
Why?
|
| Acetylation | 1 | 2021 | 1050 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 16954 | 0.150 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2020 | 484 | 0.140 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2022 | 1131 | 0.130 |
Why?
|
| Lysine | 1 | 2021 | 982 | 0.130 |
Why?
|
| Cytomegalovirus | 1 | 2020 | 750 | 0.120 |
Why?
|
| Herpesvirus 1, Human | 1 | 2021 | 739 | 0.120 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2022 | 1272 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2024 | 2846 | 0.120 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 828 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2024 | 5773 | 0.100 |
Why?
|
| DNA Damage | 1 | 2021 | 2443 | 0.090 |
Why?
|
| Cell Line | 2 | 2021 | 15545 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2020 | 5406 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2023 | 1798 | 0.060 |
Why?
|
| Humans | 8 | 2024 | 761222 | 0.060 |
Why?
|
| Virus Replication | 2 | 2023 | 2426 | 0.050 |
Why?
|
| Cell Transformation, Viral | 1 | 2023 | 526 | 0.050 |
Why?
|
| Quorum Sensing | 1 | 2022 | 136 | 0.050 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2020 | 35 | 0.040 |
Why?
|
| Crystallography | 1 | 2020 | 114 | 0.040 |
Why?
|
| Mutagens | 1 | 2020 | 179 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2022 | 511 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 543 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 579 | 0.040 |
Why?
|
| Mutation | 1 | 2020 | 30004 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 2091 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 3933 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2020 | 1807 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1448 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1589 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 2864 | 0.020 |
Why?
|
| Gene Expression | 1 | 2023 | 7571 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2022 | 3836 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2023 | 23419 | 0.020 |
Why?
|
| Apoptosis | 1 | 2023 | 9478 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3840 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2023 | 11855 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7407 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12101 | 0.010 |
Why?
|
| Female | 1 | 2021 | 392552 | 0.010 |
Why?
|
| Animals | 1 | 2022 | 168089 | 0.010 |
Why?
|